Cargando…
Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
BACKGROUND/OBJECTIVES: In the absence of consistent clinical evidence, there are concerns that fructose contributes to non-alcoholic fatty liver disease (NAFLD). To determine the effect of fructose on markers of NAFLD, we conducted a systematic review and meta-analysis of controlled feeding trials....
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975811/ https://www.ncbi.nlm.nih.gov/pubmed/24569542 http://dx.doi.org/10.1038/ejcn.2014.8 |
_version_ | 1782310192736632832 |
---|---|
author | Chiu, S Sievenpiper, J L de Souza, R J Cozma, A I Mirrahimi, A Carleton, A J Ha, V Di Buono, M Jenkins, A L Leiter, L A Wolever, T M S Don-Wauchope, A C Beyene, J Kendall, C W C Jenkins, D J A |
author_facet | Chiu, S Sievenpiper, J L de Souza, R J Cozma, A I Mirrahimi, A Carleton, A J Ha, V Di Buono, M Jenkins, A L Leiter, L A Wolever, T M S Don-Wauchope, A C Beyene, J Kendall, C W C Jenkins, D J A |
author_sort | Chiu, S |
collection | PubMed |
description | BACKGROUND/OBJECTIVES: In the absence of consistent clinical evidence, there are concerns that fructose contributes to non-alcoholic fatty liver disease (NAFLD). To determine the effect of fructose on markers of NAFLD, we conducted a systematic review and meta-analysis of controlled feeding trials. SUBJECTS/METHODS: We searched MEDLINE, EMBASE, CINAHL and the Cochrane Library (through 3 September 2013). We included relevant trials that involved a follow-up of ⩾7 days. Two reviewers independently extracted relevant data. Data were pooled by the generic inverse variance method using random effects models and expressed as standardized mean difference (SMD) for intrahepatocellular lipids (IHCL) and mean difference (MD) for alanine aminotransferase (ALT). Inter-study heterogeneity was assessed (Cochran Q statistic) and quantified (I(2) statistic). RESULTS: Eligibility criteria were met by eight reports containing 13 trials in 260 healthy participants: seven isocaloric trials, in which fructose was exchanged isocalorically for other carbohydrates, and six hypercaloric trials, in which the diet was supplemented with excess energy (+21–35% energy) from high-dose fructose (+104–220 g/day). Although there was no effect of fructose in isocaloric trials, fructose in hypercaloric trials increased both IHCL (SMD=0.45 (95% confidence interval (CI): 0.18, 0.72)) and ALT (MD=4.94 U/l (95% CI: 0.03, 9.85)). LIMITATIONS: Few trials were available for inclusion, most of which were small, short (⩽4 weeks), and of poor quality. CONCLUSIONS: Isocaloric exchange of fructose for other carbohydrates does not induce NAFLD changes in healthy participants. Fructose providing excess energy at extreme doses, however, does raise IHCL and ALT, an effect that may be more attributable to excess energy than fructose. Larger, longer and higher-quality trials of the effect of fructose on histopathological NAFLD changes are required. |
format | Online Article Text |
id | pubmed-3975811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-39758112014-04-07 Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials Chiu, S Sievenpiper, J L de Souza, R J Cozma, A I Mirrahimi, A Carleton, A J Ha, V Di Buono, M Jenkins, A L Leiter, L A Wolever, T M S Don-Wauchope, A C Beyene, J Kendall, C W C Jenkins, D J A Eur J Clin Nutr Review BACKGROUND/OBJECTIVES: In the absence of consistent clinical evidence, there are concerns that fructose contributes to non-alcoholic fatty liver disease (NAFLD). To determine the effect of fructose on markers of NAFLD, we conducted a systematic review and meta-analysis of controlled feeding trials. SUBJECTS/METHODS: We searched MEDLINE, EMBASE, CINAHL and the Cochrane Library (through 3 September 2013). We included relevant trials that involved a follow-up of ⩾7 days. Two reviewers independently extracted relevant data. Data were pooled by the generic inverse variance method using random effects models and expressed as standardized mean difference (SMD) for intrahepatocellular lipids (IHCL) and mean difference (MD) for alanine aminotransferase (ALT). Inter-study heterogeneity was assessed (Cochran Q statistic) and quantified (I(2) statistic). RESULTS: Eligibility criteria were met by eight reports containing 13 trials in 260 healthy participants: seven isocaloric trials, in which fructose was exchanged isocalorically for other carbohydrates, and six hypercaloric trials, in which the diet was supplemented with excess energy (+21–35% energy) from high-dose fructose (+104–220 g/day). Although there was no effect of fructose in isocaloric trials, fructose in hypercaloric trials increased both IHCL (SMD=0.45 (95% confidence interval (CI): 0.18, 0.72)) and ALT (MD=4.94 U/l (95% CI: 0.03, 9.85)). LIMITATIONS: Few trials were available for inclusion, most of which were small, short (⩽4 weeks), and of poor quality. CONCLUSIONS: Isocaloric exchange of fructose for other carbohydrates does not induce NAFLD changes in healthy participants. Fructose providing excess energy at extreme doses, however, does raise IHCL and ALT, an effect that may be more attributable to excess energy than fructose. Larger, longer and higher-quality trials of the effect of fructose on histopathological NAFLD changes are required. Nature Publishing Group 2014-04 2014-02-26 /pmc/articles/PMC3975811/ /pubmed/24569542 http://dx.doi.org/10.1038/ejcn.2014.8 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Review Chiu, S Sievenpiper, J L de Souza, R J Cozma, A I Mirrahimi, A Carleton, A J Ha, V Di Buono, M Jenkins, A L Leiter, L A Wolever, T M S Don-Wauchope, A C Beyene, J Kendall, C W C Jenkins, D J A Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials |
title | Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials |
title_full | Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials |
title_fullStr | Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials |
title_full_unstemmed | Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials |
title_short | Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials |
title_sort | effect of fructose on markers of non-alcoholic fatty liver disease (nafld): a systematic review and meta-analysis of controlled feeding trials |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975811/ https://www.ncbi.nlm.nih.gov/pubmed/24569542 http://dx.doi.org/10.1038/ejcn.2014.8 |
work_keys_str_mv | AT chius effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT sievenpiperjl effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT desouzarj effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT cozmaai effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT mirrahimia effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT carletonaj effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT hav effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT dibuonom effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT jenkinsal effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT leiterla effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT wolevertms effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT donwauchopeac effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT beyenej effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT kendallcwc effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials AT jenkinsdja effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials |